Both CRSP and NTLA are advancing in vivo gene editing therapies targeting large markets, with financial stability supporting ...

The goal of gene therapy is to permanently cure hereditary diseases. One of the most promising technologies for this is the ...

Labroots invites you to the 8th Annual CRISPR Virtual Event Series 2025, taking place on October 22nd, 2025! This event will explore the expanding frontier of CRISPR technology, with sessions covering ...

Scientists at The University of Texas at Austin have developed a revolutionary gene-editing method using bacterial retrons ...

MIT researchers discovered that the genome’s 3D structure doesn’t vanish during cell division as previously thought. Instead, ...

In the latest trading session, CRISPR Therapeutics AG (CRSP) closed at $67.21, marking a +1.04% move from the previous day. The stock exceeded the S&P 500, which registered a gain of 0.58% for the day ...

Algen Biotechnologies’ unique functional genomics technologies tease apart complex disease biology using human-centric therapeutic endpoints to identify novel targets and best-in-class molecules.

As enrollment numbers for the introductory chemistry and physics courses reach around 600 students each this semester, the ...

As a liberal, gay psychological researcher, my perspective on the issue of diversity, equity and inclusion policies has undergone a philosophical transformation since I began studying it intensely in ...